These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 28162931)

  • 1. Efficacy of a medication adherence enhancing intervention in transplantation: The MAESTRO-Tx trial.
    Dobbels F; De Bleser L; Berben L; Kristanto P; Dupont L; Nevens F; Vanhaecke J; Verleden G; De Geest S
    J Heart Lung Transplant; 2017 May; 36(5):499-508. PubMed ID: 28162931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved adherence to tacrolimus once-daily formulation in renal recipients: a randomized controlled trial using electronic monitoring.
    Kuypers DR; Peeters PC; Sennesael JJ; Kianda MN; Vrijens B; Kristanto P; Dobbels F; Vanrenterghem Y; Kanaan N;
    Transplantation; 2013 Jan; 95(2):333-40. PubMed ID: 23263559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Randomized Trial of a Multicomponent Intervention to Promote Medication Adherence: The Teen Adherence in Kidney Transplant Effectiveness of Intervention Trial (TAKE-IT).
    Foster BJ; Pai ALH; Zelikovsky N; Amaral S; Bell L; Dharnidharka VR; Hebert D; Holly C; Knauper B; Matsell D; Phan V; Rogers R; Smith JM; Zhao H; Furth SL
    Am J Kidney Dis; 2018 Jul; 72(1):30-41. PubMed ID: 29602631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased medication compliance of liver transplant patients switched from a twice-daily to a once-daily tacrolimus-based immunosuppressive regimen.
    Eberlin M; Otto G; Krämer I
    Transplant Proc; 2013; 45(6):2314-20. PubMed ID: 23726723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mobile medication manager application to improve adherence with immunosuppressive therapy in renal transplant recipients: A randomized controlled trial.
    Han A; Min SI; Ahn S; Min SK; Hong HJ; Han N; Kim YS; Ahn C; Ha J
    PLoS One; 2019; 14(11):e0224595. PubMed ID: 31689320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploratory Analysis of the Impact of an mHealth Medication Adherence Intervention on Tacrolimus Trough Concentration Variability: Post Hoc Results of a Randomized Controlled Trial.
    McGillicuddy JW; Chandler JL; Sox LR; Taber DJ
    Ann Pharmacother; 2020 Dec; 54(12):1185-1193. PubMed ID: 32506922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An observational study evaluating tacrolimus dose, exposure, and medication adherence after conversion from twice- to once-daily tacrolimus in liver and kidney transplant recipients.
    Bäckman L; Persson CA
    Ann Transplant; 2014 Mar; 19():138-44. PubMed ID: 24637379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating the economic implications of non-adherence and antibody-mediated rejection in renal transplant recipients: the role of once-daily tacrolimus in the UK.
    Muduma G; Odeyemi I; Pollock RF
    J Med Econ; 2015; 18(12):1050-9. PubMed ID: 26201252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Once daily tacrolimus conversion in lung transplantation: A prospective study on safety and medication adherence.
    Godinas L; Dobbels F; Hulst L; Verbeeck I; De Coninck I; Berrevoets P; Schaevers V; Yserbyt J; Dupont LJ; Verleden SE; Vanaudenaerde BM; Ceulemans LJ; Van Raemdonck DE; Neyrinck A; Verleden GM; Vos R
    J Heart Lung Transplant; 2021 Jun; 40(6):467-477. PubMed ID: 33840608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy and stability of an information and communication technology-based centralized monitoring system of adherence to immunosuppressive medication in kidney transplant recipients: study protocol for a randomized controlled trial.
    Jung HY; Seong SJ; Choi JY; Cho JH; Park SH; Kim CD; Yoon YR; Kim HK; Huh S; Yoon SH; Lee JS; Kim YL
    Trials; 2017 Oct; 18(1):480. PubMed ID: 29037222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-adherence and graft failure in adult liver transplant recipients.
    Lieber SR; Volk ML
    Dig Dis Sci; 2013 Mar; 58(3):824-34. PubMed ID: 23053889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Superior Patient and Graft Survival in Adult Liver Transplant with Rabbit Antithymocyte Globulin Induction: Experience with 595 Patients.
    Montenovo MI; Jalikis FG; Li M; Yeh M; Dick A; Hansen R; Reyes JD
    Exp Clin Transplant; 2017 Aug; 15(4):425-431. PubMed ID: 27309029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Adherence-enhancing Interventions on Adherence to Tyrosine Kinase Inhibitor Treatment in Chronic Myeloid Leukemia (TAKE-IT): A Quasi-experimental Pre-Post Intervention Multicenter Pilot Study.
    Leader A; Benyamini N; Gafter-Gvili A; Dreyer J; Calvarysky B; Amitai A; Yarchovsky-Dolberg O; Sharf G; Tousset E; Caspi O; Ellis M; Levi I; De Geest S; Raanani P
    Clin Lymphoma Myeloma Leuk; 2018 Nov; 18(11):e449-e461. PubMed ID: 30030034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Once- Versus Twice-Daily Tacrolimus Dosing on Medication Adherence in Stable Renal Transplant Recipients: A Canadian Single-Center Randomized Controlled Trial.
    Paterson TSE; Demian M; Shapiro RJ; Loken Thornton W
    Can J Kidney Health Dis; 2019; 6():2054358119867993. PubMed ID: 31452902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Once-Daily Extended-Release Tacrolimus Versus Twice-Daily Tacrolimus in De Novo Kidney Transplant Recipients: Two-Year Results of Phase 3, Double-Blind, Randomized Trial.
    Rostaing L; Bunnapradist S; Grinyó JM; Ciechanowski K; Denny JE; Silva HT; Budde K;
    Am J Kidney Dis; 2016 Apr; 67(4):648-59. PubMed ID: 26717860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of modified-release tacrolimus after conversion in liver transplant patients indicates potentially favorable outcomes in selected cohorts.
    Considine A; Tredger JM; Heneghan M; Agarwal K; Samyn M; Heaton ND; O'Grady JG; Aluvihare VR
    Liver Transpl; 2015 Jan; 21(1):29-37. PubMed ID: 25312292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of conversion from twice-daily tacrolimus (prograf) to once-daily prolonged-release tacrolimus (graceptor) in stable kidney transplant recipients.
    Nakamura Y; Hama K; Katayama H; Soga A; Toraishi T; Yokoyama T; Kihara Y; Jojima Y; Konno O; Iwamoto H; Takeuchi H; Hirano T; Shimazu M
    Transplant Proc; 2012 Jan; 44(1):124-7. PubMed ID: 22310595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomised controlled trial of a video intervention and behaviour contract to improve medication adherence after renal transplantation: the VECTOR study protocol.
    Mansell H; Rosaasen N; West-Thielke P; Wichart J; Daley C; Mainra R; Shoker A; Liu J; Blackburn D
    BMJ Open; 2019 Mar; 9(3):e025495. PubMed ID: 30872550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonspecific immunoglobulin replacement in lung transplantation recipients with hypogammaglobulinemia: a cohort study taking into account propensity score and immortal time bias.
    Claustre J; Quétant S; Camara B; France M; Schummer G; Bedouch P; Pavese P; Saint Raymond C; Bardy B; Masson D; Roth H; Pison C;
    Transplantation; 2015 Feb; 99(2):444-50. PubMed ID: 25099705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knowledge and adherence to antihypertensive therapy in primary care: results of a randomized trial.
    Amado Guirado E; Pujol Ribera E; Pacheco Huergo V; Borras JM;
    Gac Sanit; 2011; 25(1):62-7. PubMed ID: 21354671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.